Liver fatty acid binding protein (L-FABP) is the principal target protein of the hepatic carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene) in rat liver. In addition, the cyclopentenone prostaglandins (PG), PGA, PGJ2, and A'2-PGJ2, inhibit the growth of many cell types in vitro. This report describes the preferential binding of the growth inhibitory prostaglandins by L-FABP and the reversible inhibition of thymidine incorporation into DNA by PGA2 and A'2-PGJ2 in primary cultures of purified rat hepatocytes. As a model ligand, [3HJPGAI bound to L-FABP specifically, reversibly, rapidly, and with high affinity. Its dissociation constants were 134 nM (high aftmity) and 3.6 ,uM (low affiity). Early events during chemical carcinogenesis usually involve a growth inhibition that in effect localizes the proliferation of chemically transformed cells to regions of focal hyperplasia surrounded by growth-suppressed nontransformed cells (1). The liver carcinogen N-(2-fluorenyl)acetamide (2-acetylaminofluorene, FAA) is especially effective in bringing about such growth inhibition and is used for that purpose in the resistant cell model of Solt and Farber for the rapid induction of focal hyperplasia in rat liver (1). Liver fatty acid binding protein (L-FABP), generally considered to be an intracellular carrier offatty acids (2-4), is the principal early target protein of the reactive metabolites of FAA in rat liver (5, 6). L-FABP is also a minor target of the liver carcinogenic aminoazo dyes (7). The marked specificity of L-FABP as the target protein of the FAA metabolites in vivo and the exceptional ability of FAA as a growth inhibitor raised the possibility of a direct association between L-FABP and the growth inhibition of hepatocytes. This connection is further supported by the recent finding that L-FABP is also a principal target protein of selenium in mouse liver (8). Selenium compounds reversibly block cell multiplication in cultures, inhibit carcinogenesis in animals, and correlate with lower cancer mortality rates in humans (reviewed in refs. 9 and 10